# Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women

> **NCT00530582** · PHASE4 · COMPLETED · sponsor: **Max-Planck-Institute of Psychiatry** · enrollment: 10 (actual)

## Conditions studied

- Healthy
- Postmenopausal

## Interventions

- **DRUG:** progesterone

## Key facts

- **NCT ID:** NCT00530582
- **Lead sponsor:** Max-Planck-Institute of Psychiatry
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2004-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2007-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530582, "Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00530582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*